Order of IOP measurement affects results

Article

Intraocular pressure (IOP) is higher in the first eye that is measured, according to research published in Archives of Ophthalmology.

Intraocular pressure (IOP) is higher in the first eye that is measured, according to research published in Archives of Ophthalmology.

Dr Melike Pekmezci et al., Department of Ophthalmology, University of California, San Francisco, USA, conducted a study on 105 healthy participants who were randomized into 2 groups. Group 1 underwent 3 sets of 2 IOP measurements for each eye, starting with the right eye. The order of measurements was reversed for group 2. To determine the association of IOP measurement with the order measured a mixed-model, repeated-measures analysis of variance was used. This involved measurement between the first and second eyes, between the first and second visits, between the right and left eyes and with ocular squeezing.

Overall, measurements of IOP decline between first and second visits. IOP measurements were always higher in the initial eye measured, regardless of whether the right or left eye was measured first.

The results suggested that higher IOP measurements was linked to moderate and severe ocular squeezing. It is advised that multiple IOP measurements at multiple visits are crucial in the accurate diagnosis of glaucoma and ocular hypertension patients.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.